Nonparametric approach to population pharmacokinetics in oncology patients receiving aminoglycoside therapy
- 1 May 1993
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 37 (5) , 1025-1027
- https://doi.org/10.1128/aac.37.5.1025
Abstract
A nonparametric expectation maximization approach to the study of population pharmacokinetics is described for an aminoglycoside antibiotic. The method is used to explore population estimates for gentamicin clearance (liters per hour per creatinine clearance) and volume of distribution (liters per kilogram) in tumor patients. Joint and marginal probability distributions are plotted and further characterized by using standard descriptors such as mean, median, mode, standard deviation, skewness, and kurtosis. Results of additional analyses using hematologic or solid tumor subpopulations agree with those of a recent larger study which found no significant pharmacokinetic differences between these groups. Nonparametric maximum-expectation analyses are convenient and allow exploratory analysis of population estimates directly from routine laboratory information.Keywords
This publication has 7 references indexed in Scilit:
- Population Pharmacokinetics of GentamicinClinical Pharmacokinetics, 1992
- Bayesian Parameter Estimation and Population PharmacokineticsClinical Pharmacokinetics, 1992
- Gentamicin population pharmacokinetic models for low birth weight infants using a new nonparametric methodClinical Pharmacology & Therapeutics, 1991
- Gentamicin pharmacokinetics in patients with malignanciesAntimicrobial Agents and Chemotherapy, 1991
- Interlot Variability in Gentamicin and Tobramycin Concentration and Its Possible SignificanceTherapeutic Drug Monitoring, 1986
- An evaluation of population pharmacokinetics in therapeutic trials. Part I. Comparison of methodologiesClinical Pharmacology & Therapeutics, 1986
- Population PharmacokineticsClinical Pharmacokinetics, 1986